National Institutes of Health is inviting qualifying entrants for ReGen Repurposing Generic Drugs Evidence Package Challenge. The featured award or benefit is Up to US$100,000 Selected-Team Award.
Register by January 15 and submit a qualifying evidence package by March 26. Eligibility and deadlines are governed by the official rules.
Eligibility / Who Can Apply
Biomedical organizations and investigators meeting U.S. federal prize rules; preliminary registration by January 15, 2027.
Relevant Skills / Categories
- Challenge
- Challenge
- US opportunity
- Biomedical Research
Deadline: 2027-03-26
